Fig. 3From: Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosisThe plasma time-concentration profiles of gamithromycin in New Zealand rabbits received a single dose intravenous (IV) or subcutaneous (SC) administration at 6 mg/kg (n = 9 per time point). Upper right panel shows details from 0 to 4 hBack to article page